We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Filters

Equity Crowdfunding Pitches

Showing results
Using a person's face, the next generation of push notification allows a company to send and receive video and audio messages through the service to improve engagement and build trust with their business partners. 2Mee has attained a contract with a prominent gaming company, as well as six other clients taking a keen interest in the product and potentially licensing the IP.
days to go: Expired investment: £411,620
Cellmed is an immuno-oncology company that are developing treatments for ovarian cancer.  Their lead product PROCURE a dendritic cell vaccine and they are now looking to expand the treatment to target solid tumors.    
days to go: Expired investment: £520,294
The founder, Alex Papanikolaou, created Freedom One Life (FOL) due to the limitations of the stagnant powerchair market which he experienced first-hand. FOL’s vision is to deliver radical change to the market, offering a revolutionary power wheelchair to improve independence and stretch the boundaries of powerchair users. 
days to go: Expired investment: £282,016
Please watch the video for more information
days to go: Expired investment: £321,800
Please watch the video for more information
days to go: Expired investment: £328,193
Please watch the video for more information
days to go: Expired investment: £565,000
Please watch the video for more information
days to go: Expired investment: £105,986
Please watch the video for more information
days to go: Expired investment: £525,750
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph